-
Track & Monitor
Technology, Media and Telecom (TMT) Venture Capital Investments in Q2 2023
GlobalData's Venture Capital Investments in Technology, Media and Telecom (TMT) report provides detailed coverage of the global venture capital investment activity in Technology, Media and Telecom (TMT) in Q2 2023, covering key insights and trends.
-
Product Insights
Leith Grp – Halcyon Place Residential Development – Queensland
Equip yourself with the essential tools needed to make informed and profitable decisions with our Leith Grp - Halcyon Place Residential Development - Queensland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
BlackCap Halcyon – Prairies Edge Mixed-Use Development – Wisconsin
Equip yourself with the essential tools needed to make informed and profitable decisions with our BlackCap Halcyon - Prairies Edge Mixed-Use Development - Wisconsin report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Halcyon Mgt Grp – Greenpoint Mixed-Use Complex – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our Halcyon Mgt Grp - Greenpoint Mixed-Use Complex - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Spot test kits intended generally for rapid diagnosis, with immediate results, through immuno assays. Some of the tests carried out using immunochemistry rapid test include rabies virus test, allergenic food proteins, and enteric infection. The immunochemistry rapid tests and POC pipeline market research report provides comprehensive information about the immunochemistry rapid tests and POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Track & Monitor
Robotics in Medical Devices: Microfludic Lab-On-A-Chip
Innovations in medical devices industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in medical devices industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging,...
-
Track & Monitor
PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2017 Edition
Where’s your place in the CMO hierarchy? Find out in the CMO industry’s authoritative analysis of manufacturing of NDA approvals. This CMO scorecard was compiled through hundreds of professional hours of research and analysis, and is presented in a 40-page report with over 30 graphs and tables. Only CMO Scorecard enables the CMO industry to benchmark its performance over time, and CMOs to benchmark their performance against the industry. Our research team crunched the numbers on 2016 drug approvals authorized...